ARTICLE | Company News
Eligix receives CE Mark for Bcell-HDM
February 21, 2001 8:00 AM UTC
BioTransplant (BTRN) said that Eligix (Medford, Mass.) received CE mark authorization for its BCell High Density Microparticle (HDM) cell separation device to treat B cell malignancies that are normal...